A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 75.65% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 112.07%. Over the past 30 days, the price of SLS has fallen by 22.42%. And in the last five days, it has fallen by -3.35%.
The current stock price for SELLAS Life Sciences Group Inc (SLS) is $2.02. The stock experienced a significant increase during the last trading session, reaching $7.5 after opening at $2.0. It dipped to a low of $4.0 before ultimately closing at $1.98.
The market performance of SELLAS Life Sciences Group Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $2.27 on 07/02/25, with the lowest value for the same timeframe being $0.77, recorded on 12/13/24.
52-week price history of SLS Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. SELLAS Life Sciences Group Inc’s current trading price is -10.98% away from its 52-week high, while its distance from the 52-week low is 161.66%. The stock’s price range for this period has been between $0.77 and $2.27. The Healthcare sector company’s shares saw a trading volume of about 8.45 million for the day, which was higher than the average daily volume of 2.89 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
SELLAS Life Sciences Group Inc (SLS) has experienced a quarterly rise of 78.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 201.55M and boasts a workforce of 15 employees.
Expert Opinions: Analysts’ Ratings for SELLAS Life Sciences Group Inc
As of right now, 2 analysts are rating SELLAS Life Sciences Group Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4835, with a change in price of +0.7591. Similarly, SELLAS Life Sciences Group Inc recorded 2,224,835 in trading volume during the last 100 days, posting a change of +60.25%.
SLS’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for SLS stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.
SLS Stock Stochastic Average
As of today, the raw stochastic average of SELLAS Life Sciences Group Inc over the last 50 days is at 72.50%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 67.49%. Further, the company’s Stochastic %K and %D values for the last 20 days were 58.74% and 54.60%, respectively.
